lobbying_activities: 1274226

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1274226	2d55eec3-2ae5-4979-8ced-0a4b43de351f	Q2	AMERICAN PHARMACISTS ASSOCIATION	3071	AMERICAN PHARMACISTS ASSOCIATION	2012	second_quarter	PHA	HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;transitions of care;pharmacy reibursement; loan forgiveness;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;personalized medication lists;ACOs;pharmacists role in CMS Innovation Center initiatives;standardized pharmacy notice;immunization;HIT; medication disposal;biosmiliars;EHB	Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE			0	0	2012-07-19T12:40:26.670000-04:00